Monday, June 26, 2017

Mobile Bay Psychiatric Society to meet June 22, 2017

Posted by admin On June - 12 - 2017 Comments Off on Mobile Bay Psychiatric Society to meet June 22, 2017

Come and join us on June 22 to celebrate because the MBPS will be meeting regularly again! Bogan Brooks at Altapointe and I contacted many of you, and found there was plenty of interest among the community’s psychiatrists to get the MBPS meetings going again. We will serve as co-Presidents protem until the next election of a President – due February 2018.

We will start with a meeting on the Causeway, and then can rotate meetings between Mobile and Baldwin counties. We will have a private room at Felix’s and will each pay for our own dinner. So please come and get familiarized and re-acquainted.

Dr. Ronald Franks agreed to be our first speaker, and there will be CME credit available through USA College of Medicine.

Mobile Bay Psychiatric Society is a designated Chapter of the Alabama District Branch of the APA —the Alabama Psychiatric Physicians Association (APPA). There are also Chapters in Birmingham, Tuscaloosa and Montgomery.

Felix Fish Camp
1530 Battleship Pkwy
Spanish Fort, Al 36527
6:30 – 8:30 p.m. (Speaker at 7:30)

Topic: Hijacking the Brain, Understanding Addiction
Speaker: Ronald Franks, MD, DLFAPA, Professor, Acting Chair, Department of Psychiatry, USA College of Medicine

RSVP to William Bogan Brooks, MD, or Hal Veits, MD.

540-X-4-.09 Risk and Abuse Mitigation Strategies by Prescribing Physicians

Posted by admin On March - 28 - 2017 Comments Off on 540-X-4-.09 Risk and Abuse Mitigation Strategies by Prescribing Physicians

On Jan. 18, 2017, the Alabama Board of Medical Examiners approved for final adoption, proposed rule 540-X-4-.09, Risk and Abuse Mitigation Strategies (RMS) by Prescribing Physicians. This rule will became effective on March 9, 2017.

 

(1) The Board recognizes that the best available research demonstrates that the risk of adverse events occurring in patients who use controlled substances to treat pain increases as dosage increases. The Board adopts the “Morphine Milligram Equivalency” (MME) daily standard as set out by the Centers for Disease Control and Prevention (CDC) for calculating the morphine equivalence of opioid dosages.

 

(2) It is the opinion of the Board that the best practice when prescribing controlled substances for the treatment of pain shall include medically appropriate risk and abuse mitigation strategies, which will vary from patient to patient. Examples of risk and abuse mitigation strategies include, but are not limited to:

(a)  Pill counts;
(b) Urine drug screening;
(c) PDMP checks;
(d) Consideration of abuse-deterrent medications;
(e) Monitoring the patient for aberrant behavior;
(f) Providing a patient with opiate risk education prior to prescribing controlled substances; and
(g) Using validated risk-assessment tools, examples of which shall be maintained by the Board.

 

(3) For the purpose of preventing controlled substance diversion, abuse, misuse, addiction, and doctor-shopping, the Board sets forth the following requirements for the use of Alabama’s Prescription Drug Monitoring Program (PDMP):

(a) For controlled substance prescriptions totaling 30 MME or less per day, physicians are expected to use the PDMP in a manner consistent with good clinical practice.
(b) When prescribing a patient controlled substances of more than 30 MME per day, physicians shall review that patient’s prescribing history through the PDMP at least two (2) times per year, and each physician is responsible for documenting the use of risk and abuse mitigation strategies in the patient’s medical record.
(c) Physicians shall query the PDMP to review a patient’s prescribing history every time a prescription for more than 90 MME per day is written, on the same day the prescription is written.

 

(4) Exemptions: The Board’s PDMP requirements do not apply to physicians writing controlled substance prescriptions for:

(a) Nursing home patients;
(b) Hospice patients, where the prescription indicates hospice on the physical prescription;
(c) When treating a patient for active, malignant pain; or
(d) Intra-operative patient care.

 

(5) Due to the heightened risk of adverse events associated with the concurrent use of opioids and benzodiazepines, physicians should reconsider a patient’s existing benzodiazepine prescriptions or decline to add one when prescribing an opioid and consider alternative forms of treatment.

 

(6) Effective Jan. 1, 2018, each holder of an Alabama Controlled Substances Certificate (ACSC) shall acquire two (2) credits of AMA PRA Category 1™ continuing medical education (CME) in controlled substance prescribing every two (2) years as part of the licensee’s yearly CME requirement. The controlled substance prescribing education shall include instruction on controlled substance prescribing practices, recognizing signs of the abuse or misuse of controlled substances, or controlled substance prescribing for chronic pain management.

 

(7) The Board recognizes that all controlled substances, including but not limited to, opiates, benzodiazepines, stimulants, anticonvulsants, and sedative hypnotics, have a risk of addiction, misuse, and diversion. Physicians are expected to use risk and abuse mitigation strategies when prescribing any controlled substance. Additional care should be used by the physician when prescribing a patient medication from multiple controlled substance drug classes.

 

(8) A violation of this rule is grounds for the suspension, restriction, or revocation of a physician’s Alabama Controlled Substances Certificate or license to practice medicine.

Important change announced for logging Into APA website

Posted by admin On March - 16 - 2017 Comments Off on Important change announced for logging Into APA website

If you have not already done so, you will need to use a new username and password for logging into APA’s website. The new log-in requires use of the email address you have on file with APA and a new password. You can reset your password by selecting “Forgot Password?” on the account login page or by calling APA customer service at (703) 907-7300.

Your new psychiatry.org account will enable you to:
• Quickly pay your dues online, or enroll in a scheduled payment plan.
• Complete your profile to enjoy a more personalized membership experience.
• Update your email communication preferences.
• Enroll in your Members’ Course of the Month and 90+ other CME activities free to members in the APA Learning Center.